Research

Advancing medicine through research is central to the mission of the Angiogenesis Foundation. We fund and conduct research in five priority areas that the Foundation has identified as being under-studied and under-funded, but with tremendous potential for rapidly improving care on a practical level. Explore our publications.

Explore More:

HIDDEN - DONT DELETE
Prevention Research

The Angiogenesis Foundation is interested in developing methods to prevent disease through controlling angiogenesis. Angioprevention has been shown to prevent tumor development. The Foundation is studying this application through two main approaches:

  1. Using medications that can be safely taken for years (chemoprevention)
  2. Dietary prevention, using bioactive molecules present in dietary sources (fruits, vegetables, tea, herbs, etc.), to prevent angiogenesis in disease.

Specifically, the Foundation is interested in diet-based strategies for maintaining the normal healthy balance of angiogenesis regulation in the body.

Veterinary Angiogenesis

The Angiogenesis Foundation is interested in research that helps animals benefit from angiogenesis-based therapies. This creates a vital bridge between human medical research and animal health. The following areas are of specific interest:

  1. Antiangiogenic therapy approaches to pet dogs with cancer.
  2. Angiogenic growth factors therapy to speed healing in delayed closure wounds and injury in a variety of species.
Biomarkers

The Angiogenesis Foundation is interested in research that supports the understanding and development of biomarkers for disease. The following areas are of specific interest:

  1. Circulating biomarkers for the early detection of disease and monitoring effects of treatment.
  2. Functional imaging as a biomarker for angiogenesis.
Tissue Repair and Regeneration

The Angiogenesis Foundation is interested in research that advances the treatment of wounds and replaces the form and function of lost tissue through regenerative therapy. The following areas are of specific interest:

  1. Therapeutic angiogenesis.
  2. Regenerative therapies based on progenitor cells, growth factors, and gene transfer. To learn more about our Research Program, contact us.